ACM
MIRM icon

AIGH Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

AIGH Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-337,917
Closed -$5.39M – 48
2021
Q4 		$5.39M Buy
+337,917
New +$5.26M 1.64% 17
2021
Q1 		– Sell
-274,583
Closed -$4.79M – 58
2020
Q4 		$4.79M Buy
+274,583
New +$5.4M 1.95% 15

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIGH Capital Management's MIRM Position: Q1 2022 in Review

AIGH Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q1 2022, closing a stake of 337,917 shares — an estimated $5.39M sold.

AIGH Capital Management first reported a position in MIRM in Q4 2020 and held it in 2 quarters. The position peaked at $5.39M in Q4 2021. 99 funds tracked by Wall St. Rank hold MIRM as of Q1 2022.

  • AIGH Capital Management reported no remaining Mirum Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • AIGH Capital Management sold 337,917 Mirum Pharmaceuticals shares in Q1 2022, an estimated $5.39M.
  • AIGH Capital Management first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • AIGH Capital Management's Mirum Pharmaceuticals position peaked at $5.39M in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2022.

Based on AIGH Capital Management's 13F filing for Q1 2022, filed 12 May 2022.